@Vir_Biotech focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

Announces Proposed Public Offering of Common Stock
Further Details Here:➡️https://t.co/rfhbXW4hEI

#diseases #stocks #investment #biotech https://t.co/8jUs7YABpC